HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Estee Lauder

This article was originally published in The Rose Sheet

Executive Summary

Recently announced partnership with Tom Ford will benefit Estee Lauder brand by associating the cosmetics line with former Gucci designer's "leadership, authority and creativity," and even though he will create only limited-edition items for the brand, his imprint will likely impact Lauder's image for several years down the line, CEO William Lauder tells analysts during April 28 sales and earnings call. Net sales in Q3 (ended March 31) grew 8.2% to $1.54 bil., or 6% in local currencies, while net earnings were up 8% to $106.2 mil., firm reports. Skin care sales grew 9% to $608.2 mil. on a reported basis, or 6% in local currencies, company notes. Makeup revenues advanced 6% to $628.2 mil. on a reported basis, or 5% in local currencies, while fragrance sales grew 12% to $228.7 mil. on a reported basis (11% in local currencies). Hair care revenues were up 10% to $67.3 mil. on a reported basis (9% in local currencies)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013010

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel